Stephen Rogerson is Professor of Medicine in the Department of Medicine, University of Melbourne. His laboratory is based in the University’s Doherty Institute. His interests include the pathogenesis of malaria in pregnant women and young children, and the prevention of malaria in pregnancy. Recently, he has been working on a novel malaria diagnostic platform. He has long-established research links in Malawi and Papua New Guinea, where his work has been supported by the Bill & Melinda Gates Foundation, the Wellcome Trust and the National Institutes of Health.Related Projects
Related Publications
- Acquisition of antibodies against endothelial protein C receptor-binding domains of Plasmodium falciparum erythrocyte membrane protein 1 in children with severe malaria
- Acquisition of antibodies to Plasmodium falciparum and Plasmodium vivax antigens in pregnant women living in a low malaria transmission area of Brazil
- Analysis of Antibody Reactivity to Malaria Antigens by Microsphere-Based Multiplex Immunoassay
- Antibody targets on the surface of Plasmodium falciparum-infected erythrocytes that are associated with immunity to severe malaria in young children
- Associations of maternal iron deficiency with malaria infection in a cohort of pregnant Papua New Guinean women
- Burden, pathology, and costs of malaria in pregnancy: new developments for an old problem
- Decreasing malaria prevalence and its potential consequences for immunity in pregnant women
- Developing a multivariate prediction model of antibody features associated with protection of malaria-infected pregnant women from placental malaria
- Eotaxin-2 and eotaxin-3 in malaria exposure and pregnancy
- Identifying and combating the impacts of COVID-19 on malaria
- Induction, decay and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children
- Innate immune responses to malaria-infected erythrocytes in pregnant women: Effects of gravidity, malaria infection, and geographic location
- Intermittent preventive treatment for malaria in Papua New Guinean infants exposed to Plasmodium falciparum and P. vivax: a randomized controlled trial
- Iron deficiency during pregnancy is associated with a reduced risk of adverse birth outcomes in a malaria-endemic area in a longitudinal cohort study
- Low antibody levels to pregnancy-specific malaria antigens and heightened cytokine responses associated with severe malaria in pregnancy
- Malaria, malnutrition, and birthweight: A meta-analysis using individual participant data
- Microscopic and submicroscopic Plasmodium falciparum infection, maternal anaemia and adverse pregnancy outcomes in Papua New Guinea: a cohort study
- Pathogenicity and virulence of malaria: sticky problems and tricky solutions
- Placental Malaria: Tackling variants with antibodies
- Plasma cell-free DNA predicts pediatric cerebral malaria severity
- Pregnancy and Malaria: The perfect storm
- Progress towards vaccines to protect pregnant women from malaria
- Relationship of circulating Plasmodium falciparum lifecycle stage to circulating parasitemia and total parasite biomass
- Sulphadoxine-pyrimethamine plus azithromycin for the prevention of low birthweight in Papua New Guinea: a randomised controlled trial
- The impact of early life exposure to Plasmodium falciparum on the development of naturally acquired immunity to malaria in young Malawian children